Tomáš Hanke

8.3k total citations · 1 hit paper
139 papers, 5.4k citations indexed

About

Tomáš Hanke is a scholar working on Virology, Immunology and Molecular Biology. According to data from OpenAlex, Tomáš Hanke has authored 139 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Virology, 90 papers in Immunology and 58 papers in Molecular Biology. Recurrent topics in Tomáš Hanke's work include HIV Research and Treatment (115 papers), vaccines and immunoinformatics approaches (51 papers) and Immune Cell Function and Interaction (42 papers). Tomáš Hanke is often cited by papers focused on HIV Research and Treatment (115 papers), vaccines and immunoinformatics approaches (51 papers) and Immune Cell Function and Interaction (42 papers). Tomáš Hanke collaborates with scholars based in United Kingdom, United States and Japan. Tomáš Hanke's co-authors include Andrew J. McMichael, Lucy Dorrell, A J McMichael, Geoffrey L. Smith, Tom Blanchard, Edmund G. Wee, Sarah C. Gilbert, Marion Becker, Robert E. Sinden and Jörg Schneider and has published in prestigious journals such as Physical Review Letters, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Tomáš Hanke

137 papers receiving 5.2k citations

Hit Papers

Enhanced immunogenicity for CD8+ T cell induction and com... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomáš Hanke United Kingdom 38 3.0k 2.9k 2.0k 1.5k 1.2k 139 5.4k
Rama Rao Amara United States 42 3.3k 1.1× 3.7k 1.3× 1.4k 0.7× 1.8k 1.2× 1.3k 1.1× 134 5.9k
Trinity Zang United States 24 3.1k 1.0× 2.0k 0.7× 1.8k 0.9× 1.6k 1.1× 1.5k 1.2× 32 5.6k
Susan W. Barnett United States 42 2.8k 0.9× 2.8k 1.0× 1.9k 1.0× 1.5k 1.0× 1.7k 1.4× 124 5.8k
Sampa Santra United States 30 3.5k 1.2× 3.0k 1.0× 1.0k 0.5× 1.2k 0.8× 1.2k 0.9× 45 4.6k
Stuart J. D. Neil United Kingdom 41 3.9k 1.3× 3.1k 1.1× 1.8k 0.9× 2.1k 1.4× 2.0k 1.6× 89 7.3k
Deborah H. Fuller United States 31 1.2k 0.4× 2.3k 0.8× 1.4k 0.7× 1.4k 0.9× 1.2k 0.9× 77 4.2k
Michelle A. Lifton United States 35 4.0k 1.3× 3.9k 1.3× 1.6k 0.8× 1.8k 1.2× 2.0k 1.6× 73 7.0k
James Tartaglia United States 43 3.0k 1.0× 2.0k 0.7× 1.4k 0.7× 2.0k 1.3× 879 0.7× 84 5.0k
Ramesh Akkina United States 39 1.8k 0.6× 1.3k 0.4× 2.3k 1.2× 909 0.6× 1.1k 0.9× 102 4.7k
Jean Boyer United States 46 2.2k 0.7× 4.7k 1.6× 2.4k 1.2× 2.0k 1.3× 1.3k 1.1× 140 7.5k

Countries citing papers authored by Tomáš Hanke

Since Specialization
Citations

This map shows the geographic impact of Tomáš Hanke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Hanke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Hanke more than expected).

Fields of papers citing papers by Tomáš Hanke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Hanke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Hanke. The network helps show where Tomáš Hanke may publish in the future.

Co-authorship network of co-authors of Tomáš Hanke

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Hanke. A scholar is included among the top collaborators of Tomáš Hanke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Hanke. Tomáš Hanke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zaiatz-Bittencourt, Vanessa, Ciarán Bannan, Colm Bergin, et al.. (2021). Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccination. npj Vaccines. 6(1). 117–117. 3 indexed citations
3.
Moyo, Nathifa, Edmund G. Wee, Bette Korber, et al.. (2020). Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth. Vaccines. 8(3). 360–360. 18 indexed citations
4.
Kilpeläinen, Athina, Narcı́s Saubi, Nathifa Moyo, et al.. (2019). Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice. Frontiers in Immunology. 10. 923–923. 17 indexed citations
5.
Wee, Edmund G., Beatrice Ondondo, Peter Berglund, et al.. (2017). HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells. Molecular Therapy. 25(2). 494–503. 18 indexed citations
6.
Johnson, Louise A., Suneale Banerji, Uzi Gileadi, et al.. (2017). Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1. Nature Immunology. 18(7). 762–770. 146 indexed citations
7.
Borthwick, Nicola, et al.. (2014). Phase I Clinical Trial HIV-CORE002 of a Universal T-cell Vaccine: Mapping of CD8+ T Cell Epitopes. AIDS Research and Human Retroviruses. 30(S1). A187–A187. 1 indexed citations
8.
Bowles, Emma J., Torben Schiffner, Maximillian Rosario, et al.. (2014). Comparison of Neutralizing Antibody Responses Elicited from Highly Diverse Polyvalent Heterotrimeric HIV-1 gp140 Cocktail Immunogens versus a Monovalent Counterpart in Rhesus Macaques. PLoS ONE. 9(12). e114709–e114709. 10 indexed citations
9.
Hopkins, R.M., Anne Bridgeman, Joan Joseph, et al.. (2011). Dual Neonate Vaccine Platform against HIV-1 and M. tuberculosis. PLoS ONE. 6(5). e20067–e20067. 26 indexed citations
10.
Hopkins, R.M., Anne Bridgeman, Jerald Sadoff, et al.. (2011). Optimizing HIV‐1‐specific CD8+ T‐cell induction by recombinant BCG in prime‐boost regimens with heterologous viral vectors. European Journal of Immunology. 41(12). 3542–3552. 24 indexed citations
11.
Teoh, Denise, Louise A. Johnson, Tomáš Hanke, Andrew J. McMichael, & David G. Jackson. (2009). Blocking Development of a CD8+ T Cell Response by Targeting Lymphatic Recruitment of APC. The Journal of Immunology. 182(4). 2425–2431. 32 indexed citations
12.
Winstone, Nicola, Ana Guimarães‐Walker, Denise Scott Brown, et al.. (2009). Increased detection of proliferating, polyfunctional, HIV‐1‐specific T cells in DNA‐modified vaccinia virus Ankara‐vaccinated human volunteers by cultured IFN‐γ ELISPOT assay. European Journal of Immunology. 39(4). 975–985. 22 indexed citations
13.
Hopkins, Robert, John P. Fulkerson, Narcı́s Saubi, et al.. (2008). Vaccine Platform for Prevention of Mother-to-Child Transmission of HIV-1 through Breastfeeding. AIDS Research and Human Retroviruses. 24. 137–137. 1 indexed citations
14.
Im, Eung‐Jun & Tomáš Hanke. (2007). Short Communication: Preclinical Evaluation of Candidate HIV Type 1 Vaccines in Inbred Strains and an Outbred Stock of Mice. AIDS Research and Human Retroviruses. 23(7). 857–862. 13 indexed citations
15.
Estcourt, Marie J., Sven Létourneau, Andrew J. McMichael, & Tomáš Hanke. (2005). Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responses. European Journal of Immunology. 35(9). 2532–2540. 49 indexed citations
16.
17.
Wade-Evans, A.M., Jim Stott, Tomáš Hanke, et al.. (2001). Specific Proliferative T Cell Responses and Antibodies Elicited by Vaccination with Simian Immunodeficiency Virus Nef Do Not Confer Protection against Virus Challenge. AIDS Research and Human Retroviruses. 17(16). 1517–1526. 6 indexed citations
18.
Allen, Todd M., Thorsten U. Vogel, Deborah H. Fuller, et al.. (2000). Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen. The Journal of Immunology. 164(9). 4968–4978. 213 indexed citations
19.
20.
Hanke, Tomáš, Rusung Tan, Andrew J. McMichael, et al.. (1998). Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.. Journal of General Virology. 79(1). 83–90. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026